Overhauling clinical trials

Nat Biotechnol. 2007 Mar;25(3):287-92. doi: 10.1038/nbt0307-287.

Authors

Christopher Thomas Scott¹, Monya Baker

Affiliation

¹ Program on Stem Cells in Society, Stanford Center for Biomedical Ethics, Stanford, California, USA. cscott@stanford.edu

PMID: 17344876
DOI: 10.1038/nbt0307-287

No abstract available

MeSH terms

Clinical Trials as Topic / legislation & jurisprudence
Clinical Trials as Topic / methods*
Clinical Trials as Topic / standards
Cost Control
Drug Approval
Drug Industry
Humans
Randomized Controlled Trials as Topic / methods*
Randomized Controlled Trials as Topic / statistics & numerical data
Research Design*
United States
United States Food and Drug Administration